Marina A. Malikova, PhD

Assistant Professor, Surgery

Marina Malikova
88 E. Newton St Newton Pavilion

Biography

Dr. Malikova graduated from the Institute of Biochemistry, Russian Academy of Science, in Moscow, Russia with a PhD in Biochemistry. She has a strong background in biomedical sciences and has completed her postdoctoral fellowship in the field of cell signaling and cell migration. She also holds a Master’s Degree in Clinical Investigation and Project Management Certification from Boston University.

In her current role as Executive Director, Dr. Malikova manages research efforts in seven divisions of the Department of Surgery at Boston Medical Center. She is responsible for clinical trials and basic biomedical research operations, risk management, strategic planning, and macro-management of research programs. She provides guidance and oversight to the Project Managers, Clinical Research Associates (CRAs), Clinical Research Coordinators (CRCs), and laboratory staff. She also provides assistance to investigators with protocol and informed consent writing, regulatory submissions, clinical trial agreements and budget development.

Other Positions

  • Executive Director, Surgical Translational Research Operations and Compliance, Boston University Chobanian & Avedisian School of Medicine

Publications

  • Published on 10/26/2022

    Malikova M.A., Cole A., Trifirò G.; Racagni G., Van Liew D., Webster P., Brahmbhatt T. Frontiers in Drug Safety and Regulation. Establishing patient safety monitoring in the benefit-risk paradigm for off-label and emergency use of medications for COVID-19: A pharmacovigilance perspective. EPub. https://doi.org/10.3389/fdsfr.2022.1038235. 2022; 1-6.

    Read at: Custom
  • Published on 10/14/2022

    Malikova M.A. The Symposium on Advanced Wound Care (SAWC). October 13-16th, 2022, Las Vegas, Nevada, USA.Abstract Book. Building Quality by Design into Wound Care Trials with Combination Products. 2022; 83-84.

    Read at: Custom
  • Published on 9/23/2022

    Malikova M., Webster P., Brahmbhatt T. 21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities” 20–23, September 2022 Verona, Italy. Establishing Patient Safety Monitoring in the Benefit-Risk Paradigm for Off-Label and Emergency Use of Medications for COVID-19: A Pharmacovigilance Perspective. Drug Safety. Drug Safety. 2022; (45):1199–1200.

    Read at: Custom
  • Published on 9/23/2022

    Malikova M. and Kaliaev A. 21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities”. Risk-Based Quality and Safety Management in Clinical Trials with Combination Devices in Changing Global Regulatory Environment. Drug Safety. Drug Safety. 2022; (45):1267.

    Read at: Custom
  • Published on 9/23/2022

    Palin K., V. Kugener V., Salas M., Malikova M., Price J., Webster P., Cole A., Ely D., Habibi S., Joshi P. 21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities”. Am2P: A New Accredited Academic Training Program in Pharmacovigilance and Pharmacoepidemiology Designed for US, Canadian and Caribbean Healthcare Professionals. Drug Safety. 2022; (45):1275–1276.

    Read at: Custom
  • Published on 9/5/2022

    Cole A, Webster P, Van Liew D, Salas M, Aimer O, Malikova MA. Safety surveillance and challenges in accelerated COVID-19 vaccine development. Ther Adv Drug Saf. 2022; 13:20420986221116452. PMID: 36072284.

    Read at: PubMed
  • Published on 5/21/2022

    Li Y, He Y, Falzon I, Fairbourn B, Tingey S, Imrey PB, Radeva MK, Beck GJ, Gassman JJ, Roy-Chaudhury P, Berceli SA, Cheung AK, Shiu YT. Dynamic Remodeling of Human Arteriovenous Fistula Wall Obtained From Magnetic Resonance Imaging During the First 6 Months After Creation. Kidney Int Rep. 2022 Aug; 7(8):1905-1909. PMID: 35967120.

    Read at: PubMed
  • Published on 1/1/2022

    Malikova M, Jara H, Slanetz PJ. Evaluation of non-palpable breast lesions by quantitative magnetic resonance imaging in correlation with histopathology and radiological findings. 2022.

    Read at: Custom
  • Published on 3/17/2021

    Malikova M.A. Optimizing Protocol Design for Special Populations: Evolving Challenges. Annual Europe Meeting, Drug Information Association (DIA EUROPE 2021), March 15-19, 2021, Basel, Switzerland. Abstract ID: 86126. 2021.

  • Published on 3/15/2021

    Malikova M.A. Annual Europe Meeting, Drug Information Association (DIA EUROPE 2021), March 15-19, 2021, Basel, Switzerland. Safety and Risk Based Quality Management in Clinical Trials with Cell- Based Combination Products. 2021; Abstract ID: 92115.

View 57 more publications: View full profile at BUMC

View all profiles